Kaluga, Russia
AstraZeneca opened a pharmaceutical manufacturing facility in October of 2015 in Kaluga, Russia. The dedicated center will focus on final-stage production, packaging, and quality control. The development cost of the project to date is $224 million. Commercial production is expected to begin at the site in early 2016 with full operations commencing in 2017.
